Found "Health Promotion": 1,056 results
Sort by
Relevance

Growing Older Together: Is ASEAN Ready for Happy Ageing?

Living longer is inevitable. Living better requires policy choices. Happy ageing is achieved through policy impact, not policy volume. ASEAN does not lack ageing policies — it lacks evidence on what works. While many Member States have introduced national plans, pensions, and health programme

Early Health Technology Assessment of herbal extracts for Metabolic Syndrome

The project aims to evaluate the cost-effectiveness, economic impact, and feasibility of integrating this herbal innovation into Thailand’s healthcare system. By applying Early HTA techniques, this study will provide insights for decision-makers, improve resource allocation, and support future investments in innovative medical solutions.67301075M

Development of a practical guidebook on Medical Technology Development

This project aims to develop a practical guidebook on medical technology development. It is funded by the Department of Medical Sciences, Ministry of Public Health, and aims to explain the concepts, processes, and outcomes of medical technology development in the Thai context. This guidebook is intended to serve as a reliable internal reference doc

Meeting Summary: Global Antibiotic Policy Initiative (GAPi) Internal Meeting

Acknowledgements This report was prepared by Dr. Zin Nwe Win, Dr. Shiela Marie Selisana, and Ms. Thitipanchaya Panya from the Health Intervention and Technology Assessment Program Foundation (HITAP) and reviewed by Ms. Saudamini Vishwanath Dabak. The meeting was conducted in collaboration with

Good Governance for Universal Health Coverage

Achieving universal health coverage (UHC) requires policy initiatives supported by long-term system reform and an accountable governance structure that can sustainably deliver all three dimensions of UHC, population coverage, breadth of benefits package, and degree of financial coverag

Using Health Technology Assessment to address inefficient and unequal use of Nilotinib across Indonesia

It is vital to have evidence-informed clinical practice guidelines or clinical indications to guide the usage of high-cost drugs in the benefits package under the Indonesian universal health coverage (JKN), managed by BPJS Kesehatan. A transparent and legit mechanism is required to support and mo
10 / Page